Experientia supplementum (2012)

Using Small Noncoding RNAs to Study and Treat Cancer: Challenges and Possible Solutions

Updated

Abstract

Small interfering RNAs (siRNAs), consisting of 21-25 nucleotides, are crucial for gene silencing and cellular regulation.

  • siRNAs play a critical role in RNA interference, degrading specific mRNA targets to prevent protein synthesis.
  • They are involved in essential cellular processes such as development, immune response, and stress response.
  • Improper regulation of siRNAs may contribute to diseases like cancer and viral infections.
  • In cancer research, siRNAs may selectively silence oncogenes, potentially hindering tumor progression.
  • Challenges for siRNA-based therapies include issues with efficient delivery, off-target effects, and stability.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free